The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis.

Cottrell, Tricia R; Wise, Robert A; Wigley, Fredrick M; Boin, Francesco

Cottrell, Tricia R; Wise, Robert A; Wigley, Fredrick M; Boin, Francesco.

Affiliation

Cottrell TR; Johns Hopkins University School of Medicine, , Baltimore, Maryland, USA.

Ann Rheum Dis ; 73(6): 1060-6, 2014 Jun.

Article in En | MEDLINE | ID: mdl-23606705

Subject(s)

Lung Diseases; Scleroderma, Systemic/pathology; Skin/pathology; Adult; Antibodies, Antinuclear/immunology; Autoantibodies/immunology; Cohort Studies; DNA Topoisomerases, Type I; Disease Progression; Female; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Lung Diseases/etiology; Lung Diseases/mortality; Male; Middle Aged; Nuclear Proteins/immunology; Prognosis; Proportional Hazards Models; Retrospective Studies; Scleroderma, Systemic/complications; Scleroderma, Systemic/immunology; Scleroderma, Systemic/mortality

Key words

Autoantibodies; Pulmonary Fibrosis; Systemic Sclerosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Scleroderma, Systemic / Skin / Lung Diseases Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Rheum Dis Year: 2014 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google